vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Simpson Manufacturing Co., Inc. (SSD). Click either name above to swap in a different company.
Simpson Manufacturing Co., Inc. is the larger business by last-quarter revenue ($588.0M vs $493.8M, roughly 1.2× Pediatrix Medical Group, Inc.). Simpson Manufacturing Co., Inc. runs the higher net margin — 15.0% vs 6.8%, a 8.2% gap on every dollar of revenue. On growth, Simpson Manufacturing Co., Inc. posted the faster year-over-year revenue change (9.1% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -0.8%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Simpson Manufacturing Company is a leading building materials manufacturer in the United States that produces structural connectors, fasteners, anchors, and products for new construction and retrofitting.
MD vs SSD — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $588.0M |
| Net Profit | $33.7M | $88.2M |
| Gross Margin | — | 45.2% |
| Operating Margin | 9.9% | 19.5% |
| Net Margin | 6.8% | 15.0% |
| Revenue YoY | -1.7% | 9.1% |
| Net Profit YoY | 10.5% | 13.3% |
| EPS (diluted) | $0.40 | $2.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $588.0M | ||
| Q4 25 | $493.8M | $539.3M | ||
| Q3 25 | $492.9M | $623.5M | ||
| Q2 25 | $468.8M | $631.1M | ||
| Q1 25 | $458.4M | $538.9M | ||
| Q4 24 | $502.4M | $517.4M | ||
| Q3 24 | $511.2M | $587.2M | ||
| Q2 24 | $504.3M | $597.0M |
| Q1 26 | — | $88.2M | ||
| Q4 25 | $33.7M | $56.2M | ||
| Q3 25 | $71.7M | $107.4M | ||
| Q2 25 | $39.3M | $103.5M | ||
| Q1 25 | $20.7M | $77.9M | ||
| Q4 24 | $30.5M | $55.4M | ||
| Q3 24 | $19.4M | $93.5M | ||
| Q2 24 | $-153.0M | $97.8M |
| Q1 26 | — | 45.2% | ||
| Q4 25 | — | 43.4% | ||
| Q3 25 | — | 46.4% | ||
| Q2 25 | — | 46.7% | ||
| Q1 25 | — | 46.8% | ||
| Q4 24 | — | 44.0% | ||
| Q3 24 | — | 46.8% | ||
| Q2 24 | — | 46.7% |
| Q1 26 | — | 19.5% | ||
| Q4 25 | 9.9% | 13.9% | ||
| Q3 25 | 13.8% | 22.6% | ||
| Q2 25 | 12.8% | 22.2% | ||
| Q1 25 | 7.0% | 19.0% | ||
| Q4 24 | 7.8% | 14.8% | ||
| Q3 24 | 6.6% | 21.3% | ||
| Q2 24 | -31.3% | 22.1% |
| Q1 26 | — | 15.0% | ||
| Q4 25 | 6.8% | 10.4% | ||
| Q3 25 | 14.5% | 17.2% | ||
| Q2 25 | 8.4% | 16.4% | ||
| Q1 25 | 4.5% | 14.5% | ||
| Q4 24 | 6.1% | 10.7% | ||
| Q3 24 | 3.8% | 15.9% | ||
| Q2 24 | -30.3% | 16.4% |
| Q1 26 | — | $2.13 | ||
| Q4 25 | $0.40 | $1.34 | ||
| Q3 25 | $0.84 | $2.58 | ||
| Q2 25 | $0.46 | $2.47 | ||
| Q1 25 | $0.24 | $1.85 | ||
| Q4 24 | $0.37 | $1.31 | ||
| Q3 24 | $0.23 | $2.21 | ||
| Q2 24 | $-1.84 | $2.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $341.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.1B |
| Total Assets | $2.2B | $3.0B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $341.0M | ||
| Q4 25 | $375.2M | $384.1M | ||
| Q3 25 | $340.1M | $297.3M | ||
| Q2 25 | $224.7M | $190.4M | ||
| Q1 25 | $99.0M | $150.3M | ||
| Q4 24 | $229.9M | $239.4M | ||
| Q3 24 | $103.8M | $339.4M | ||
| Q2 24 | $19.4M | $354.9M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | $300.0M | ||
| Q3 25 | $577.2M | $371.3M | ||
| Q2 25 | $583.9M | $376.9M | ||
| Q1 25 | $590.5M | $382.5M | ||
| Q4 24 | $597.1M | $388.1M | ||
| Q3 24 | — | $393.8M | ||
| Q2 24 | — | $399.4M |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $865.9M | $2.0B | ||
| Q3 25 | $890.7M | $2.0B | ||
| Q2 25 | $833.8M | $1.9B | ||
| Q1 25 | $789.2M | $1.9B | ||
| Q4 24 | $764.9M | $1.8B | ||
| Q3 24 | $732.5M | $1.9B | ||
| Q2 24 | $706.5M | $1.8B |
| Q1 26 | — | $3.0B | ||
| Q4 25 | $2.2B | $3.1B | ||
| Q3 25 | $2.2B | $3.0B | ||
| Q2 25 | $2.1B | $3.0B | ||
| Q1 25 | $2.0B | $2.8B | ||
| Q4 24 | $2.2B | $2.7B | ||
| Q3 24 | $2.1B | $2.9B | ||
| Q2 24 | $2.0B | $2.8B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | 0.15× | ||
| Q3 25 | 0.65× | 0.19× | ||
| Q2 25 | 0.70× | 0.20× | ||
| Q1 25 | 0.75× | 0.21× | ||
| Q4 24 | 0.78× | 0.21× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.23× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $155.7M | ||
| Q3 25 | $137.3M | $170.2M | ||
| Q2 25 | $137.2M | $125.2M | ||
| Q1 25 | $-117.5M | $7.6M | ||
| Q4 24 | $133.0M | $115.8M | ||
| Q3 24 | $91.8M | $103.3M | ||
| Q2 24 | $107.0M | $111.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $119.0M | ||
| Q3 25 | — | $133.9M | ||
| Q2 25 | — | $87.3M | ||
| Q1 25 | — | $-42.6M | ||
| Q4 24 | — | $60.3M | ||
| Q3 24 | — | $58.1M | ||
| Q2 24 | — | $70.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 22.1% | ||
| Q3 25 | — | 21.5% | ||
| Q2 25 | — | 13.8% | ||
| Q1 25 | — | -7.9% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 11.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.8% | ||
| Q3 25 | — | 5.8% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 7.7% | ||
| Q2 24 | — | 6.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 2.77× | ||
| Q3 25 | 1.91× | 1.58× | ||
| Q2 25 | 3.49× | 1.21× | ||
| Q1 25 | -5.66× | 0.10× | ||
| Q4 24 | 4.36× | 2.09× | ||
| Q3 24 | 4.72× | 1.10× | ||
| Q2 24 | — | 1.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SSD
Segment breakdown not available.
